Previous close | 579.37 |
Open | 572.52 |
Bid | 561.00 x 800 |
Ask | 579.58 x 800 |
Day's range | 576.19 - 580.93 |
52-week range | 415.60 - 603.82 |
Volume | |
Avg. volume | 1,614,508 |
Market cap | 220.764B |
Beta (5Y monthly) | 0.80 |
PE ratio (TTM) | 37.42 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.56 (0.27%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | N/A |
WALTHAM, Mass., March 01, 2024--Thermo Fisher Scientific Inc. (NYSE: TMO) ("Thermo Fisher"), the world leader in serving science, announced that its wholly owned subsidiary, Orion Acquisition AB (the "Buyer"), has extended the expiration time of the offering period of its previously announced tender offer (the "Offer") to acquire all of the outstanding common shares ("Shares") and all of the outstanding American Depositary Shares, each representing one Share ("ADSs" and, together with the Shares
Thermo Fisher Scientific, the world leader in serving science, will significantly expand local operations in Indonesia with the opening of its first official office. The inauguration of the new facility in Jakarta is scheduled for April, signifying a key milestone as the company transitions from its current representative office to a larger workspace.
WALTHAM, Mass., February 28, 2024--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present at the TD Cowen Health Care Conference on Wednesday, March 6, 2024 at 9:10 a.m. (EST).